These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19799637

  • 1. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1.
    Odds FC.
    FEMS Yeast Res; 2009 Oct; 9(7):1091-101. PubMed ID: 19799637
    [Abstract] [Full Text] [Related]

  • 2. Population structure and properties of Candida albicans, as determined by multilocus sequence typing.
    Tavanti A, Davidson AD, Fordyce MJ, Gow NA, Maiden MC, Odds FC.
    J Clin Microbiol; 2005 Nov; 43(11):5601-13. PubMed ID: 16272493
    [Abstract] [Full Text] [Related]

  • 3. Molecular epidemiology of invasive Candida albicans at a tertiary hospital in northern Taiwan from 2003 to 2011.
    Wang SH, Shen M, Lin HC, Sun PL, Lo HJ, Lu JJ.
    Med Mycol; 2015 Nov; 53(8):828-36. PubMed ID: 26333357
    [Abstract] [Full Text] [Related]

  • 4. Azole-resistant Candida albicans from a wild Brazilian porcupine (Coendou prehensilis): a sign of an environmental imbalance?
    Castelo-Branco DS, Brilhante RS, Paiva MA, Teixeira CE, Caetano EP, Ribeiro JF, Cordeiro RA, Sidrim JJ, Monteiro AJ, Rocha MF.
    Med Mycol; 2013 Jul; 51(5):555-60. PubMed ID: 23286353
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL, Edlind TD.
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [Abstract] [Full Text] [Related]

  • 6. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
    Hu Y, Hu Y, Lu Y, Huang S, Liu K, Han X, Mao Z, Wu Z, Zhou X.
    Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates.
    Basma R, Barada G, Ojaimi N, Khalaf RA.
    Mycoses; 2009 Mar; 52(2):141-8. PubMed ID: 18627469
    [Abstract] [Full Text] [Related]

  • 8. Candida albicans bloodstream isolates in a German university hospital are genetically heterogenous and susceptible to commonly used antifungals.
    Huyke J, Martin R, Walther G, Weber M, Kaerger K, Bougnoux ME, Elias J, Kurzai O.
    Int J Med Microbiol; 2015 Oct; 305(7):742-7. PubMed ID: 26324013
    [Abstract] [Full Text] [Related]

  • 9. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Oct; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 10. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.
    Jacobsen MD, Boekhout T, Odds FC.
    FEMS Yeast Res; 2008 Aug; 8(5):764-70. PubMed ID: 18547330
    [Abstract] [Full Text] [Related]

  • 11. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
    Khodavandi A, Alizadeh F, Vanda NA, Karimi G, Chong PP.
    Pharm Biol; 2014 Dec; 52(12):1505-9. PubMed ID: 24863276
    [Abstract] [Full Text] [Related]

  • 12. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI, Ogbonnaya UL.
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [Abstract] [Full Text] [Related]

  • 13. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M, Müller FM.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
    [Abstract] [Full Text] [Related]

  • 14. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM, Prigitano A, Biraghi E, Viviani MA, FIMUA-ECMM Candidaemia Study Group.
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [Abstract] [Full Text] [Related]

  • 15. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J, Sharp A, Moore CB, Warn PA, Denning DW.
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [Abstract] [Full Text] [Related]

  • 16. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.
    J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
    [Abstract] [Full Text] [Related]

  • 17. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV, Pavliuk TD.
    Mikrobiol Z; 2003 Sep; 65(5):26-9. PubMed ID: 14723159
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
    Barchiesi F, Falconi Di Francesco L, Scalise G.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
    [Abstract] [Full Text] [Related]

  • 19. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L, Yang HF, Liu YY, Xu XH, Ye Y, Li JB.
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [Abstract] [Full Text] [Related]

  • 20. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group.
    Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.